UY26885A1 - Activadores de la tetrazolil-fenil acetamido glucoquinasa - Google Patents
Activadores de la tetrazolil-fenil acetamido glucoquinasaInfo
- Publication number
- UY26885A1 UY26885A1 UY26885A UY26885A UY26885A1 UY 26885 A1 UY26885 A1 UY 26885A1 UY 26885 A UY26885 A UY 26885A UY 26885 A UY26885 A UY 26885A UY 26885 A1 UY26885 A1 UY 26885A1
- Authority
- UY
- Uruguay
- Prior art keywords
- activators
- glucoquinasa
- tetrazolil
- phenyl acetamido
- phenyl
- Prior art date
Links
- 239000012190 activator Substances 0.000 title abstract 2
- 102000030595 Glucokinase Human genes 0.000 abstract 1
- 108010021582 Glucokinase Proteins 0.000 abstract 1
- 230000003914 insulin secretion Effects 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22549400P | 2000-08-15 | 2000-08-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY26885A1 true UY26885A1 (es) | 2002-02-28 |
Family
ID=22845106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY26885A UY26885A1 (es) | 2000-08-15 | 2001-08-14 | Activadores de la tetrazolil-fenil acetamido glucoquinasa |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US6369232B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1311504B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP3961948B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR100518061B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1209362C (cg-RX-API-DMAC7.html) |
| AR (1) | AR031718A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE297921T1 (cg-RX-API-DMAC7.html) |
| AU (2) | AU2001283998B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0113312A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2419416C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60111540T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1311504T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2243541T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03001275A (cg-RX-API-DMAC7.html) |
| PA (1) | PA8525201A1 (cg-RX-API-DMAC7.html) |
| PE (1) | PE20020386A1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1311504E (cg-RX-API-DMAC7.html) |
| UY (1) | UY26885A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002014312A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200300904B (cg-RX-API-DMAC7.html) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| US7087631B2 (en) * | 2002-07-18 | 2006-08-08 | Inotek Pharmaceuticals Corporation | Aryltetrazole compounds, and compositions thereof |
| US7078423B2 (en) * | 2002-07-18 | 2006-07-18 | Inotek Pharmaceuticals Corporation | 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
| CN101805358A (zh) * | 2002-10-03 | 2010-08-18 | 诺瓦提斯公司 | 作为葡糖激酶激活剂、可用于治疗ⅱ型糖尿病的取代的(噻唑-2-基)酰胺或磺酰胺 |
| GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| MY141521A (en) | 2002-12-12 | 2010-05-14 | Hoffmann La Roche | 5-substituted-six-membered heteroaromatic glucokinase activators |
| AU2003294376A1 (en) * | 2003-01-06 | 2004-08-10 | Eli Lilly And Company | Heteroaryl compounds |
| PL378117A1 (pl) * | 2003-02-11 | 2006-03-06 | Prosidion Limited | Tricyklopodstawione związki amidowe |
| US7262196B2 (en) * | 2003-02-11 | 2007-08-28 | Prosidion Limited | Tri(cyclo) substituted amide glucokinase activator compounds |
| WO2005095418A1 (en) | 2004-04-02 | 2005-10-13 | Novartis Ag | Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of type 2 diabetes |
| CA2561157A1 (en) | 2004-04-02 | 2005-10-13 | Novartis Ag | Thiazolopyridine derivatives, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions |
| EP1902052B1 (en) | 2005-07-09 | 2012-11-28 | AstraZeneca AB | Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| BRPI0613451A2 (pt) | 2005-07-11 | 2011-01-11 | Mitsubishi Tanabe Pharma Corp | ativador de glicocinase, derivado de oxima, método para a preparação do referido derivado de oxima e uso |
| RU2008112184A (ru) | 2005-08-31 | 2009-10-10 | Астеллас Фарма Инк. (Jp) | Производное тиазола |
| JP2007063225A (ja) * | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| CN101272784A (zh) | 2005-09-29 | 2008-09-24 | 塞诺菲-安万特股份有限公司 | 苯基-和吡啶基-1,2,4-噁二唑酮衍生物、它们的制备方法和它们作为药物的用途 |
| GT200600429A (es) | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
| GT200600428A (es) | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
| JP2009514835A (ja) * | 2005-11-03 | 2009-04-09 | プロシディオン・リミテッド | トリシクロ置換型アミド |
| US20070197532A1 (en) * | 2005-11-18 | 2007-08-23 | Cao Sheldon X | Glucokinase activators |
| BRPI0619980A2 (pt) * | 2005-12-15 | 2014-10-14 | Nihon Nohyaku Co Ltd | Derivados de ftalamida e de anilina, inseticida agrícola ou hortícula, e, método de uso do mesmo |
| US8034822B2 (en) | 2006-03-08 | 2011-10-11 | Takeda San Diego, Inc. | Glucokinase activators |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| EP2049518B1 (en) | 2006-05-31 | 2011-08-31 | Takeda San Diego, Inc. | Indazole and isoindole derivatives as glucokinase activating agents. |
| US7910747B2 (en) * | 2006-07-06 | 2011-03-22 | Bristol-Myers Squibb Company | Phosphonate and phosphinate pyrazolylamide glucokinase activators |
| US7902248B2 (en) | 2006-12-14 | 2011-03-08 | Hoffmann-La Roche Inc. | Oxime glucokinase activators |
| EP2091947A2 (en) | 2006-12-20 | 2009-08-26 | Takeda San Diego, Inc. | Glucokinase activators |
| TW200831081A (en) | 2006-12-25 | 2008-08-01 | Kyorin Seiyaku Kk | Glucokinase activator |
| EP2105435A4 (en) * | 2007-01-10 | 2011-06-15 | Mitsubishi Tanabe Pharma Corp | Hydrazone derivative |
| EP2116533B1 (en) | 2007-03-07 | 2013-07-10 | Kyorin Pharmaceutical Co., Ltd. | Glucokinase activator |
| US8173645B2 (en) * | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
| AU2008310519B2 (en) * | 2007-10-08 | 2013-05-02 | Advinus Therapeutics Private Limited | Acetamide derivatives as glucokinase activators, their process and medicinal applications |
| CL2009000004A1 (es) * | 2008-01-15 | 2010-02-19 | Lilly Co Eli | Forma cristalina de r-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida; composicion farmaceutica que comprende a dicha forma cristalina; y uso para el tratamiento de diabetes o hiperglicemia. |
| KR20100113518A (ko) * | 2008-01-18 | 2010-10-21 | 아스텔라스세이야쿠 가부시키가이샤 | 페닐아세트아미드 유도체 |
| NZ588462A (en) | 2008-04-28 | 2012-07-27 | Kyorin Seiyaku Kk | Cyclopentylacrylic acid amide derivative |
| ES2624780T3 (es) | 2010-03-31 | 2017-07-17 | The Scripps Research Institute | Reprogramación de células |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3776917A (en) * | 1972-06-05 | 1973-12-04 | Schering Corp | 2-amino-6-phenalkyl-aminopyridines and derivatives thereof |
| GB8909574D0 (en) | 1989-04-26 | 1989-06-14 | Ici Plc | Chemical process |
| US5859052A (en) * | 1993-01-14 | 1999-01-12 | G. D. Searle & Co. | Fatty acid analogs and prodrugs |
| US5468867A (en) * | 1994-05-27 | 1995-11-21 | Syntex (U.S.A.) Inc. | Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid |
| US5461049A (en) * | 1994-05-27 | 1995-10-24 | Warner-Lambert Company | Amide tetrazole ACAT inhibitors |
| TR199902442T2 (xx) * | 1997-01-28 | 2000-07-21 | Merck & Co.,Inc. | �eker ve �i�manl�k tedavisinde �3 agonistleri olarak tiazol benzens�lfonamidler. |
| TR200102805T2 (tr) * | 1999-03-29 | 2002-04-22 | F.Hoffmann-La Roche Ag | Glikokinaz aktivatörleri |
-
2001
- 2001-08-08 US US09/924,247 patent/US6369232B1/en not_active Expired - Fee Related
- 2001-08-09 BR BR0113312-8A patent/BR0113312A/pt not_active IP Right Cessation
- 2001-08-09 AU AU2001283998A patent/AU2001283998B2/en not_active Ceased
- 2001-08-09 WO PCT/EP2001/009207 patent/WO2002014312A1/en not_active Ceased
- 2001-08-09 DK DK01962926T patent/DK1311504T3/da active
- 2001-08-09 DE DE60111540T patent/DE60111540T2/de not_active Expired - Lifetime
- 2001-08-09 CN CNB018163475A patent/CN1209362C/zh not_active Expired - Fee Related
- 2001-08-09 EP EP01962926A patent/EP1311504B1/en not_active Expired - Lifetime
- 2001-08-09 JP JP2002519452A patent/JP3961948B2/ja not_active Expired - Fee Related
- 2001-08-09 PT PT01962926T patent/PT1311504E/pt unknown
- 2001-08-09 MX MXPA03001275A patent/MXPA03001275A/es active IP Right Grant
- 2001-08-09 ES ES01962926T patent/ES2243541T3/es not_active Expired - Lifetime
- 2001-08-09 KR KR10-2003-7002231A patent/KR100518061B1/ko not_active Expired - Fee Related
- 2001-08-09 AU AU8399801A patent/AU8399801A/xx active Pending
- 2001-08-09 CA CA002419416A patent/CA2419416C/en not_active Expired - Fee Related
- 2001-08-09 AT AT01962926T patent/ATE297921T1/de not_active IP Right Cessation
- 2001-08-14 PA PA20018525201A patent/PA8525201A1/es unknown
- 2001-08-14 UY UY26885A patent/UY26885A1/es not_active Application Discontinuation
- 2001-08-14 AR ARP010103886A patent/AR031718A1/es active IP Right Grant
- 2001-08-15 PE PE2001000814A patent/PE20020386A1/es not_active Application Discontinuation
- 2001-10-11 US US09/975,713 patent/US6388088B1/en not_active Expired - Fee Related
-
2002
- 2002-01-16 US US10/050,508 patent/US6441180B1/en not_active Expired - Fee Related
-
2003
- 2003-01-31 ZA ZA200300904A patent/ZA200300904B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001283998B2 (en) | 2005-10-20 |
| CN1209362C (zh) | 2005-07-06 |
| ZA200300904B (en) | 2004-04-30 |
| CA2419416A1 (en) | 2002-02-21 |
| DE60111540T2 (de) | 2006-03-16 |
| KR100518061B1 (ko) | 2005-09-28 |
| JP2004506632A (ja) | 2004-03-04 |
| AU8399801A (en) | 2002-02-25 |
| EP1311504A1 (en) | 2003-05-21 |
| CN1466584A (zh) | 2004-01-07 |
| KR20030022408A (ko) | 2003-03-15 |
| US6441180B1 (en) | 2002-08-27 |
| US6369232B1 (en) | 2002-04-09 |
| EP1311504B1 (en) | 2005-06-15 |
| CA2419416C (en) | 2009-10-13 |
| PE20020386A1 (es) | 2002-05-13 |
| US20020035267A1 (en) | 2002-03-21 |
| PA8525201A1 (es) | 2002-07-30 |
| AR031718A1 (es) | 2003-10-01 |
| ES2243541T3 (es) | 2005-12-01 |
| DE60111540D1 (de) | 2005-07-21 |
| JP3961948B2 (ja) | 2007-08-22 |
| US20020065275A1 (en) | 2002-05-30 |
| DK1311504T3 (da) | 2005-10-17 |
| BR0113312A (pt) | 2003-07-01 |
| WO2002014312A1 (en) | 2002-02-21 |
| ATE297921T1 (de) | 2005-07-15 |
| PT1311504E (pt) | 2005-10-31 |
| MXPA03001275A (es) | 2003-06-30 |
| US20020035266A1 (en) | 2002-03-21 |
| US6388088B1 (en) | 2002-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26885A1 (es) | Activadores de la tetrazolil-fenil acetamido glucoquinasa | |
| ECSP014054A (es) | Activadores de glucoquinasa alquinil fenil heteroaromatica | |
| ECSP014067A (es) | Activadores de fenil glucoquinasa para-aril o heterociclico sustituida | |
| UY28005A1 (es) | Indol -3-carboxamidas como activadores de glucoquinasa (gk) | |
| DK1349856T3 (da) | Isoindolin-1-on-glucokinase-aktivatorer | |
| ECSP045382A (es) | Fenilacetamidas sustituidas y su uso como activadores de glucoquinasa | |
| ECSP014055A (es) | Activadores de glucoquinasa que contienen hidantoina | |
| UY26695A1 (es) | Activadores para amino sustituidos de la fenilamida glucoquinasa | |
| ECSP105178A (es) | Compuestos de aril urea en combinación con otros agentes citostáticos o citotóxicos para el tratamiento de cáncer en humanos | |
| DE60035032D1 (de) | Verwendung von pioglitazone zur verbesserung der ketose und der azidose | |
| ATE412387T1 (de) | Medizinische vorrichtungen | |
| SG130189A1 (en) | Substituted indole-o-glucosides | |
| UA86042C2 (en) | Substituted indazole-o-glucosides | |
| ATE534649T1 (de) | Imidazothiazole und imidazoxazolderivative als inhibitoren von p38 | |
| BRPI0607351A2 (pt) | métodos para tratamento de linfomas empregando uma combinação de agente quimioterapêutico e il-2 e opcionalmente um anticorpo anti-cd20 | |
| CY1114254T1 (el) | Ενδοφλεβια ενεση μη νευροτοξικων ενεργοποιητων του πλασμινογονου για την αντιμετωπιση του εγκεφαλικου επεισοδιου | |
| ECSP056057A (es) | Compuestos de benzo[1,2,5]tiadiazole | |
| UY26690A1 (es) | Activadores heteroaromáticos de la alquinil - fenil glucoquinasa | |
| BRPI0510407A (pt) | derivados de 3-amino-2-fenilpirrolidina | |
| ECSP034651A (es) | Activadores de glucocinasa isoindolin-1-ona | |
| UY26080A1 (es) | Nuevas dihidropirimidinas | |
| UA4196U (uk) | Поліфіт-прополіс - біологічно активна домішка для профілактики та лікування інфекційних захворювань, туберкульозу, виразкової хвороби, підвищення імунітету |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20140917 |